Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways

At present, there is no specific anti-metastasis drug in HCC treatment. Drugs used for primary HCC tumors and tumor metastasis are very similar, among which cytotoxic drugs are prevalent, such as cisplatin, doxorubicin and 5-FU. The EGFR pathway plays an important role in promoting hepatocellular ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jianhong, Pei, Heying, Luo, Hong, Fu, Afu, Yang, Hansuo, Hu, Jia, Zhao, Chengjian, Chai, LuLu, Chen, Xiang, Shao, Ximing, Wang, Chunyu, Wu, Wenshuang, Wan, Li, Ye, Haoyu, Qiu, Qiang, Peng, Aihua, Wei, Yuquan, Yang, Li, Chen, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352206/
https://www.ncbi.nlm.nih.gov/pubmed/27906672
http://dx.doi.org/10.18632/oncotarget.13687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352206/
https://www.ncbi.nlm.nih.gov/pubmed/27906672
http://dx.doi.org/10.18632/oncotarget.13687

Ejemplares similares